Drug-induced injury has attracted increasing attention in public health issues. Among them, hepatotoxicity has been regarded as the leading clinical problem caused by drug toxicity. However, owing to the complexity of the involved pathophysiological mechanisms and the lack of noninvasive, straightforward, and real-time tools, drug-induced hepatotoxicity has rarely been predicted satisfactorily. In this paper, by utilizing the reactive species peroxynitrite (ONOO À ) as a biomarker, we present a two-photon fluorescent probe, TP-KA, holding rapid response, high specificity and sensitivity towards ONOO À , to investigate drug (acetaminophen and tolcapone)-related liver injury and the remediate effect of N-acetyl cysteine (NAC). With the support of TP-KA, we obtained direct and visual evidence of the upregulation of ONOO À during drug challenge both in live cells and mice, which was accompanied by liver tissue injury and tyrosine nitration. These findings demonstrate that ONOO À is a good and appropriate biomarker of hepatotoxicity, and nitrosative stress may be necessary for acetaminophen and tolcapone to exert their toxicity. Moreover, TP-KA can be employed as a powerful tool to pre-detect drug-induced organism injury and study the effect of antidotes.
Introduction
Drug-induced injury, as a long-term concern, has attracted increasing attention as a public health issue. Moreover, it is cited as the most common reason for an approved drug to be withdrawn from the market, or labelled with a black box warning. 1, 2 Attributed to the central role of transforming and clearing exogenous and endogenous xenobiotics from the human body, the liver is oen the most susceptible to damage by drugs, which ultimately results in hepatotoxicity being regarded as the leading clinical problem. [3] [4] [5] As such, the preclinical investigation of drug-induced hepatotoxicity is required to improve patient safety and therapeutic treatment.
Unfortunately, owing to the complexity of the involved pathophysiological mechanisms, drug-induced hepatotoxicity has rarely been predicted satisfactorily. [6] [7] [8] In general, it is reported that the reactive metabolites formed from drugs are responsible for most cases of hepatotoxicity, [9] [10] [11] which are usually accompanied by the generation of reactive small molecules, including reactive oxygen species (ROS) and reactive nitrogen species (RNS). 12, 13 Therefore, ROS and RNS might be employed as biomarkers to predict drug-related hepatotoxicity. 8, 14 Peroxynitrite (ONOO À ), a kind of RNS which is generated by the diffusion-limited reaction of superoxide anion radicals (O 2 c À ) with nitric oxide (NO), could be an excellent alternative because of its high oxidative and nitrosative activity towards biomolecules. 15, 16 Hence, the efficient tracking of ONOO À during drug challenge will add benets to the in-depth understanding of the hepatotoxicity mechanism. However, the elusive nature of ONOO À under physiological conditions, 17 and its properties such as an extremely short half-life (<10 ms), nanomolar homeostasis concentration, and high chemical reactivity, precludes its direct tracking in situ. Recently, uo-rescence imaging has gained much attention for its outstanding properties in terms of direct visualization and satised temporal and spatial resolution, [18] [19] [20] [21] [22] [23] [24] [25] and a number of uores-cent probes have been developed for ONOO À detection in biological systems. [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] Nonetheless, few probes have been utilized to investigate the role ONOO À plays in drug-induced hepatotoxicity, 8 especially probes with two-photon excitability since two-photon probes show the advantages of deep tissue penetration, less photodamage, and good resolution.
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In this work, a new two-photon uorescent probe, TP-KA, was designed and synthesized for ONOO À detection with a rapid response, high specicity, and good sensitivity. By capitalizing on its outstanding features, TP-KA was successfully employed in exploring hepatotoxicity events caused by two drugs, namely the analgesic and antipyretic drug, acetaminophen (APAP), and the anti-Parkinson's disease drug, tolcapone. Encouragingly, with the aid of TP-KA, we veried that the hepatotoxicity mechanism of these two drugs was involved in ONOO À upregulation, which was accompanied by liver tissue injury and tyrosine nitration. Moreover, the remediation of the drug-induced damage was achieved using N-acetyl cysteine (NAC), which might serve as a superior alternative antidote through enhancing the nontoxic metabolism of these drugs. These results demonstrated that through efficient ONOO À evaluation, TP-KA may be a powerful tool to pre-detect clinical drug-induced liver damage and to study the effect of the antidote.
Results and discussion
Design, synthesis, spectral properties, and reactivity The tert-butyl ester group was introduced to increase lipophilicity and thus enabled TP-KA to penetrate through cell membranes smoothly. We anticipated that TP-KA presented weak and blue-shied uo-rescence emission because the intramolecular charge transfer (ICT) effect was weakened by the electron-withdrawing aketoamide group. Once it had reacted with ONOO À , the uo-rophore 1,8-naphthalimide would be released and emit striking uorescence that was attributed to the restored ICT process (Scheme 1).
The synthetic procedure is displayed in Scheme S1. † With TP-KA and compound 1 in hand, their spectral properties were rstly assessed in 50 mM PBS buffer (pH 7.4, 1% DMSO) at 37 C. As can be seen in Fig. S1 , † TP-KA itself displayed its maximal absorbance/emission at 375 nm/454 nm. Due to the weakened ICT effect caused by a-ketoamide, TP-KA showed a spectral blue shi compared to its reaction product 1 (430 nm/ 560 nm). In addition, TP-KA showed a negligible uorescence signal when excited at 430 nm. Therefore, to obtain a high signal-to-noise ratio, the following in vitro detection systems were all excited at 430 nm. Subsequently, the reactivity of TP-KA towards H 2 O 2 and ONOO À was evaluated ( 
Kinetic investigation of TP-KA
The kinetic characteristics of TP-KA were investigated (Fig. S3 †) . In the absence of ONOO À , the constant and weak uorescence intensity indicated that TP-KA presented a low background signal and was stable towards light irradiation. In the presence of ONOO À , a rapid and drastic uorescence enhancement was observed within 40 s, and then leveled off, hinting that TP-KA was able to efficiently capture ONOO À in spite of its short lifetime and high activity.
The specicity of TP-KA towards ONOO
À
The specicity of TP-KA towards ONOO À was examined. Gratifyingly, as illustrated in Fig. 1 (mM). The limit of detection (LOD) was calculated to be as low as 25 nM based on 3 s/k (where s is the standard deviation of 11 blank samples, and k is the slope of the linear graph), which enabled TP-KA to be sensitive enough for tracing ONOO À in the biosystems. Furthermore, the effect of pH was investigated (Fig. S4 †) . In the absence of ONOO À , the uorescence intensity of TP-KA itself remained unchanged at the wide pH range 5.0-9.0, indicating that TP-KA was hardly inuenced by the pH. Meanwhile, upon the addition of ONOO À , unchanged and strong uorescence signals were detected in the pH range 5.0-9.0, which well covered the pH range of physiological environments. Therefore, combined with the results of its outstanding response behavior, TP-KA exhibits robust analytical potential for biological applications.
The proposed mechanism for the sensing of ONOO
The reaction mechanism of TP-KA with ONOO À was further conrmed using high resolution mass spectrometer analysis (Fig. S5 †) . Upon the incubation of TP-KA with ONOO À for 10 min, the reaction mixture was found to have mass peaks at m/z ¼ 341.1672 and m/z ¼ 166.0194, corresponding to compound 1 and the byproduct 4-nitrobenzoic acid, respectively. Both the spectral variations and the mass analysis results strongly validated the proposed sensing mechanism displayed in Scheme S2. †
Two-photon uorescence properties of TP-KA
The two-photon absorption cross-section (d) of TP-KA and its sensing product 1 were investigated, as d is a critical parameter for a two-photon imaging probe. The d max values of TP-KA and compound 1 were acquired at 800 nm and were 95 GM (1 GM ¼ 10 À50 m 4 s per photon) and 193 GM, respectively. The higher two-photon absorption cross-section of compound 1 over TP-KA could be attributed to its electron donating moiety, the 4-amino group. Moreover, the high d max value enabled TP-KA to be applied in two-photon uorescence microscopy imaging.
Visualizing exogenous ONOO À in live cells
Encouraged by the notable response properties of TP-KA, the feasibility of it mapping the ONOO À level in biological systems
was assessed with a two-photon excitation microscopy (TPM) system. Prior to cell imaging, an MTT assay was performed to identify the cytotoxicity of TP-KA, and the results (Fig. S6 †) implied that TP-KA presented excellent biocompatibility (IC 50 ¼ 63 mM). Then, utilizing SIN-1 as the ONOO À donor, exogenous ONOO À imaging was performed in HepG2 cells. As displayed in Fig. 3 , in the control group, a negligible uorescence signal was observed in the cells loaded with TP-KA. Contrastingly, a signicant enhancement of the intracellular uorescence intensity was obtained upon SIN-1 exposure, which was efficiently stopped by uric acid, an ONOO À scavenger. Furthermore, the bright eld images displayed intact cells, implying the good viability of the cells throughout the experiment. Consequently, the data conrmed that TP-KA showed promise to act as a mapping tool to explore ONOO À uctuations under biological conditions.
Imaging drug-induced hepatotoxicity and the remediation effect of NAC
Normally, hepatotoxicity corresponds to chemical-driven liver damage. 44 It is well-known that an overdose of acetaminophen (APAP), a common household medication used to treat pain and fever, could induce hepatotoxicity related to the overproduction of ROS and RNS. 45 Therefore, by guiding with the imaging biomarker ONOO À , APAP-induced damage was visualized in cells, with the aid of TP-KA. As presented in Fig. 4a -e, aer the treatment of APAP, a notably stronger uorescence signal in HepG2 cells was detected than that observed under normal conditions. Therefore, the results revealed that intracellular ONOO À was upregulated under the administration of APAP, thus contributing to oxidative and nitrosative stress injury. Furthermore, as can be seen in the gure, the strong uores-cence intensity could be effectively attenuated by N-acetyl cysteine (NAC), which remediated cell injury via the depletion of the ROS and RNS levels by increasing the GSH level and binding with the toxic products of APAP. 46, 47 Therefore, the results indicated that TP-KA exhibited excellent properties for visualizing the cell damage induced by APAP and NAC displayed a good antidotal effect.
Then, the cell injury of another drug, tolcapone, was explored. Tolcapone was used initially for the treatment of Parkinson's disease, but it was withdrawn from the market in the EU and labelled with a black box warning in the US because of its severe hepatotoxicity. 48, 49 No clear mechanism has been proposed regarding tolcapone-induced liver toxicity yet. But it has been hypothesized that it is associated with dysfunctional mitochondrial respiration due to the uncoupling of oxidative phosphorylation.
50 Accordingly, using TP-KA, injury due to tolcapone in cells was mapped to explore the possible injury mechanism (Fig. 4f-j) . As can be seen in the gure, the HepG2 cells that were exposed to tolcapone demonstrated brighter, dose-dependent uorescence compared to the control group, suggesting the upregulation of the ONOO À level. This means that, as well as APAP, tolcapone could also induce HepG2 cell damage via the overproduction of ONOO À through the induction of oxidative and nitrosative stress. Meanwhile, the apparent decrease in the uorescence intensity of cells treated with NAC before the tolcapone treatment implied the remedial role of NAC in tolcapone-induced cell damage. Subsequently, the hepatotoxicity of APAP and tolcapone was visualized in tissues to strongly verify the toxicity mechanism. Generally, Kunming mice were divided into three groups. For the control group, the mice were administered an intraperitoneal injection of PBS buffer before being given a tail-vein injection of TP-KA. The second group was given an intraperitoneal injection of PBS buffer solution containing various concentrations of APAP or tolcapone, and then a tail-vein injection of TP-KA 30 min later. The mice in the last group were pretreated with an intraperitoneal injection of NAC 1 h before drug administration. Then all of the mice were anesthetized and dissected to isolate their livers, which were cut into slices for TPM uorescence imaging. As shown in Fig. 5 , weak uorescence intensity was obtained in the mice liver tissue of the control group, implying a low ONOO À level under normal conditions. In contrast, aer the administration of either APAP or tolcapone, the mice liver tissue of the second group emitted obvious uorescence, indicating up-regulated ONOO À aer drug treatment. Meanwhile, for the mice pretreated with NAC before drug administration, negligible uorescence signal change was observed in both the APAP and tolcapone group, conrming the protective effect of NAC in the liver. These results veried that both APAP and tolcapone could induce hepatotoxicity via the upregulation of ONOO À .
Next, the histological and immunohistochemical analysis on the liver tissues were carried out to identify the histological changes during the drug administration. Nitrotyrosine was employed as the immunohistochemical biomarker to conrm the nitrosative stress of ONOO À to protein tyrosine residues.
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Briey, Kunming mice liver sections were prepared from the three groups that were processed under various conditions, including PBS buffer only, drug administration, and NAC pretreatment. As can be seen in Fig. 6 and S7, † both the histological changes (i.e., cellular shrinkage or blebbing, the rupture of the cell membrane, and the condensation of chromatin) and nitrotyrosine formation could be obviously observed aer the administration of the two drugs, implying that the liver injury happened because of the drug metabolism. However, the mice in the NAC pretreatment group displayed no distinct changes in the histological and immunohistochemical analysis, indicating that the liver injury could be effectively suppressed by NAC. Taken together, these results were in good agreement with the observation of in vitro uorescence imaging using ONOO À as a biomarker (Fig. 4 and 5) .
Finally, tolcapone-induced hepatotoxicity and NAC remediation were monitored in vivo through a real-time method. As can be seen from Fig. 7 , aer tolcapone administration, the uo-rescence intensities of the mice livers displayed gradual increments in a time-dependent manner. In particular, the observable uorescence intensity augmentation at 15 min indicated that ONOO À -related stress began to show up aer drug administration in such a short time. In addition, the clearance assay was also performed using uric acid to conrm the overproduction of ONOO À aer tolcapone administration.
Moreover, with the passage of time, no obvious intensity augmentation was observed in the NAC pretreatment group, indicating effective NAC remediation aer the drug treatment.
It should be noted that for the rst time, the early warning potential of ONOO À for tolcapone-induced hepatotoxicity was revealed and demonstrated explicitly using TP-KA.
Conclusions
In conclusion, we have constructed a new two-photon uores-cent probe, TP-KA, for ONOO À detection. Using the excellent properties of TP-KA, ONOO À as a biomarker for APAP-and tolcapone-induced hepatotoxicity was exploited. It was found that an apparent ONOO À level upregulation occurred during the drug-induced liver damage, and N-acetyl cysteine (NAC) might serve as a superior alternative antidote against the toxic metabolism of the drugs. In particular, the early warning potential of ONOO À for tolcapone-induced hepatotoxicity was revealed. Therefore, we anticipate that TP-KA may be employed as a powerful tool to pre-detect drug-induced organism injury and study the effect of antidotes.
